Professional Overview

Dan Komarek is a seasoned executive and investor with a strong background in the life sciences industry, currently serving as an Angel Investor at Keiretsu Forum and a Strategic Business Advisor at Life Science Consultant. His key expertise areas include strategic planning, business development, and leadership, with a focus on the biotechnology and life sciences sectors.

Experience Summary

Current Role

Dan Komarek is currently an Angel Investor at Keiretsu Forum, where he invests in and advises early-stage companies in the life sciences industry. As a Strategic Business Advisor at Life Science Consultant, he provides guidance and support to companies in the industry. His key responsibilities include identifying investment opportunities, advising portfolio companies, and providing strategic guidance to clients.

Career Progression

Dan Komarek has had a notable career progression, with previous roles including President/GM of MTI-GlobalStem division at Thermo Fisher Scientific, President/COO at MTI-GlobalStem, Biotechnology Business Advisor at Biotech Consulting, Director, Strategic Planning at BD Biosciences, Director, Gene Discovery Services at Life Technologies, and Study Director - BioAnalytical Services at Bioreliance. Throughout his career, he has demonstrated strong leadership and management capabilities, with a focus on driving business growth and innovation.

Areas of Expertise

Dan Komarek's areas of expertise include:
Industry-specific skills: biotechnology, life sciences, strategic planning, business development
Technical competencies: gene discovery, bioanalytical services, stem cell technology
* Leadership and management capabilities: team management, business strategy, investment analysis

Professional Impact

Dan Komarek has made significant contributions to the life sciences industry, with notable projects and initiatives including his work as President/GM of MTI-GlobalStem division at Thermo Fisher Scientific and his investments in early-stage companies as an Angel Investor at Keiretsu Forum.

Conclusion

In conclusion, Dan Komarek is a highly experienced and accomplished executive and investor in the life sciences industry. With a strong background in strategic planning, business development, and leadership, he continues to make significant contributions to the industry through his work as an Angel Investor and Strategic Business Advisor. His current focus is on investing in and advising early-stage companies, and his value proposition lies in his ability to provide strategic guidance and support to companies in the industry.